newsfilter
← Latest News
GlobeNewswire·

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update

– LOQTORZI® net revenue of $13.6 million in Q2 2026, up 15% over Q1 – – Clinical data continue to mature across programs with emerging evidence of activity with tagmokitug in head and neck cancer – – Projected October